Zuzana Cermakova

Zuzana Cermakova

Auto-generated profile, based on publicly available information

Zuzana Cermakova

Blood Center, University Hospital Ostrava, Ostrava, Czech Republic

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2021 in Blood
Verified
Journal Article
Closed access
PDF file
ETErika Tarasco
Erika Tarasco
LBLukas Bütikofer
Lukas Bütikofer
KFKenneth D. Friedman
Kenneth D. Friedman
JGJames N. George
James N. George
IHIngrid V Hrachovinova
Ingrid V Hrachovinova
JHJohanna A. Kremer Hovinga
Johanna A. Kremer Hovinga
Hereditary thrombotic thrombocytopenic purpura (hTTP) is a rare thrombotic microangiopathy characterized by severe congenital ADAMTS13 deficiency and recurring acute episodes causing morbidity and premature death. Information on the annual incidence and severity of acute episodes in patients with hTTP is largely lacking. This study reports prospective data on 87 patients from the Hereditary TTP Registry (clinicaltrials.gov #NCT01257269) for survival, frequency, and severity of acute episodes from enrollment until December 2019. The 87 patients, followed up for a median of 4.2 years (range, 0.01-15 years), had a median age at overt disease onset and at clinical diagnosis of 4.6 years and 18 years (range, 0.0-70 years for both), respectively. Forty-three patients received regular plasma prophylaxis, whereas 22 did not, and treatment changed over time or was unknown in the remaining 22. Forty-three patients experienced 131 acute episodes, of which 91 (69%) occurred in patients receiving regular prophylaxis. This resulted in an annual incidence of acute episodes of 0.36 (95% confidence interval [CI], 0.29-0.44) with regular plasma treatment and of 0.41 (95% CI, 0.30-0.56) without regular plasma treatment. More than one-third of acute episodes (n = 51) were documented in children 40 years (1.18 [95% CI, 0.88-1.55] vs 0.14 [95% CI, 0.08-0.23]). The prophylactic plasma infusion regimens used were insufficient to prevent acute episodes in many patients. Such regimens are burdensome, and caregivers, patients, and their guardians are reluctant to start regular plasma infusions, from which children particularly would benefit.

5 November 2018 in Journal of Clinical Apheresis
Verified
Journal Article
Closed access
PDF file
PKPetra Kovarova
Petra Kovarova
RHRadomira Hrdlickova
Radomira Hrdlickova
SBSarka Blahutova
Sarka Blahutova
ZCZuzana Cermakova
Zuzana Cermakova

1 April 2013
Verified
Journal Article
Closed access
ZCZ Cermáková
Z Cermáková
OSO Simetka
O Simetka
MKM Kořístka
M Kořístka

8 December 2012 in Open Medicine
Verified
Journal Article
Open access
PDF file
ZCZuzana Cermakova
Zuzana Cermakova
PKPetra Kucerova
Petra Kucerova
ZVZbynek Valenta
Zbynek Valenta
LPLenka Pliskova
Lenka Pliskova
RBRadka Bolehovska
Radka Bolehovska
BVBarbora Voxova
Barbora Voxova
This retrospective study aims to identify and describe the problems associated with the laboratory and clinical diagnosis of leptospirosis. A total of 4,813 patients with suspected leptospirosis from an area of the Czech Republic, with a total population of 1.15 million, were examined during the period 2002–2010. Our study included only 855 patients: 545 men (mean age 41.03 ± 19.24) and 310 women (mean age 41.47 ± 20.3) who were examined using microscopic agglutination test (MAT) and a polymerase chain reaction (PCR). All patients and their physicians filled in questionnaires, which included anamnestic data, clinical symptoms and the results of laboratory tests. Out of total suspected, 89 patients (1.85%), tested positive for leptospirosis, of which 50 have been examined only serologically by MAT. Of 855 patients in our study undergoing both PCR and MAT tests, 39 have tested positive for leptospirosis. The most frequent symptom in patients with leptospirosis included fever (91.6%) and headache (69.4%). The correct laboratory diagnosis of leptospirosis depends on biological material being tested before the start of antibiotic treatment, since leptospires are extremely sensitive to antibiotics. Consequently, the PCR results alone may produce a false negative result after 24 hours following treatment with antibiotics.

23 June 2014 in Biomedical Papers
Verified
Journal Article
Open access
PDF file
ZCZuzana Cermakova
Zuzana Cermakova
SBSarka Blahutova
Sarka Blahutova
TPTomas Papajik
Tomas Papajik
DGDana Galuszkova
Dana Galuszkova
JHJaromir Hubacek
Jaromir Hubacek
MSMartina Sommerova
Martina Sommerova
Background: Granulocyte apheresis is a safe and effective method for granulocyte collection. We present a five year experience (2006-2010) of the Blood Center, Faculty Hospital Ostrava, Czech Republic. Donor granulocyte transfusion is one treat...

1 April 2013
Verified
Journal Article
Closed access
ZCZ Cermáková
Z Cermáková
RHR Hrdličková
R Hrdličková
SBS Blahutová
S Blahutová
ALA Ligová
A Ligová